IGDB.NSCLC Gene View
 
Gene Information        (help)
Gene CAV2 Ensembl ENSG00000105971 Chromosome 7 Start 115926680 End 115935830
Description Caveolin-2 [Source:UniProtKB/Swiss-Prot;Acc:P51636]
GENE RESOURCES :NUCLEOTIDE SEQUENCES :PROTEIN RESOURCES :CLINICAL RESOURCES :REFERENCES :
     HGNC : 1528
     Entrez Gene : 858
     UCSC : uc003vid.2
     GeneCards : 1528
     RefSeq : NM_001233
     CCDS : CCDS5765.1
     Uniprot : P51636
     Interpro : P51636
     OMIM : 601048
     GeneTests : CAV2
     CGAP : CAV2
     PMID : 8552590

< Top >


Experimental Evidence        (help)
Expression Sample Number Method Clinical information PubMed Reference
down 114/159(72%) IHC- 15095482 J Pathol 2004, 203(1): 584-93

< Top >


Microarray Gene Expression Fold Change Result        (help)
( red: up-regulation / green : down-regulation when p value < 0.01)
( gray background : these probesets might have mapping problems. ref 1, ref 2)
Chip Type Probeset Adenocarcinoma Squamous Cell Carcinoma
Fold Change p value q value Fold Change p value q value
 HG_U95  339_at  -1.96  3.69e-18  1.88e-16  -1.38  1.81e-8  1.59e-7
 HG_U95  40168_at  -0.38  2.52e-2  5.16e-2  -0.25  3.04e-1  4.07e-1
 HG_U133A  203323_at  -2.63  5.91e-93  2.03e-90  -3.61  8.04e-134  1.49e-132
 HG_U133A  203324_s_at  -1.77  2.59e-37  6.19e-36  -2.75  9.45e-108  7.94e-107
 HG_U133A  213426_s_at  -0.88  3.89e-11  1.53e-10  1.81  6.66e-55  1.64e-54
 HG_U133_Plus2  203323_at  -2.58  2.30e-54  3.15e-51  -2.26  4.49e-36  4.51e-34
 HG_U133_Plus2  203324_s_at  -1.88  5.92e-29  3.61e-27  -1.80  1.01e-21  1.71e-20
 HG_U133_Plus2  213426_s_at  -0.83  3.53e-7  1.71e-6  -0.28  5.11e-2  7.31e-2
 Stanford  5426  -2.36  3.48e-7  6.51e-5  -2.06  2.66e-6  1.92e-4
 Stanford  10602  -2.01  2.61e-6  2.67e-4  -1.52  6.22e-5  1.93e-3
 Stanford  19325  -2.86  4.58e-11  1.23e-7  -2.35  7.40e-8  1.63e-5
 Agilent_HS_21.6K  7492  -0.01  8.80e-1  9.33e-1  0.05  3.66e-1  5.27e-1

< Top >


Adjuvant Cisplatin/vinorelbine Treatment vs Observation Result        (help) (Pubmed)
( red: up-regulation / green : down-regulation when p value < 0.01)
( gray background color : the mapping problems of probeset. ref_1, ref_2)
Chip Type Probeset Adenocarcinoma Squamous Cell Carcinoma
Fold Change p value q value Fold Change p value q value
 HG_U133A  203323_at  -0.38  3.87e-1  8.96e-1  -0.12  5.58e-1  1.00e+0
 HG_U133A  203324_s_at  -0.33  3.95e-1  8.97e-1  -0.41  1.08e-1  1.00e+0
 HG_U133A  213426_s_at  -0.15  7.63e-1  9.75e-1  -0.44  2.42e-1  1.00e+0

< Top >


Microarray Sample Data        (help)
( The log2 value of tumor samples )
(Average : Average log2 value from Normal Samples.)
        HG_U95 - 339_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U95 - 40168_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133A - 203323_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133A - 203324_s_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133A - 213426_s_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 203323_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 203324_s_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 213426_s_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Stanford - 5426    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Stanford - 10602    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Stanford - 19325    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Agilent_HS_21.6K - 7492    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

< Top >


Cancer Gene Index        (help)

If 0 entry was found, please remove the search key "lung cancer".
Keyword DiseaseData Statement PubMed Organism
caveolin-2 tumour In addition, several genes, such as caveolin-1 (CAV1) and caveolin-2 (CAV2), were constantly deregulated in all types of tumour sample, compared with normal tissue. 15095482 Human
cav2 tumour In addition, several genes, such as caveolin-1 (CAV1) and caveolin-2 (CAV2), were constantly deregulated in all types of tumour sample, compared with normal tissue. 15095482 Human
cav2 tumours Immunostaining for CAV1 was negative in 48% of tumours, whereas 28% of the tumours did not express CAV2. 15095482 Human
caveolin 2 human colon cancer In this work, we showed that in Caco-2 cells, a polarized cell line derived from human colon cancer that does not express caveolin 1 (Cav-1), there was no detectable expression of caveolin 2 (Cav-2). 12414992 Human
cav-2 human colon cancer In this work, we showed that in Caco-2 cells, a polarized cell line derived from human colon cancer that does not express caveolin 1 (Cav-1), there was no detectable expression of caveolin 2 (Cav-2). 12414992 Human
caveolin-2 adenocarcinoma of the colon We studied the expression of caveolin-1 and caveolin-2 in normal epithelium, adenoma, and adenocarcinoma of the colon and their possible role in tumorigenesis. 11345836 Human
caveolin-2 adenoma We studied the expression of caveolin-1 and caveolin-2 in normal epithelium, adenoma, and adenocarcinoma of the colon and their possible role in tumorigenesis. 11345836 Human
caveolin-2 carcinomas Expression of caveolin-2 was undetectable in all of the normal colonic glands, adenomas, and carcinomas. 11345836 Human
caveolin-2 adenomas Expression of caveolin-2 was undetectable in all of the normal colonic glands, adenomas, and carcinomas. 11345836 Human
caveolin-2 human neuroblastoma Although caveolin proteins were long thought to be absent from the brain, we have shown that the human neuroblastoma cell line LAN-1 expresses both caveolin-1 and caveolin-2. 10646519 Human
cav tumor The corresponding genes in humans (CAV and CAV2, respectively), have been mapped to a common locus in chromosome 7q31.1, and are possible candidates for the tumor suppressor gene postulated in this region. 10675615 Human
cav2 tumor The corresponding genes in humans (CAV and CAV2, respectively), have been mapped to a common locus in chromosome 7q31.1, and are possible candidates for the tumor suppressor gene postulated in this region. 10675615 Human
cav c6 glioma Here, we have undertaken the immunochemical identification of CAV and the known caveolin isoforms (1alpha, 1beta, 2 and 3) in cultured rat C6 glioma cells. 10568687 Rat
caveolin-2 c6 glioma Immunoblot analysis revealed that particulate fractions from rat C6 glioma cells express caveolin-1 and caveolin-2. 10568687 Rat
cav c6 glioma In addition, they demonstrate that cultured C6 glioma cells can be useful as a model system to study the role of CAV and caveolins in subcellular transport and signal transduction events in glial cells and the brain. 10568687 Rat
caveolin-2 cancer With the exception of Calu-1 cell line, all cancer cell lines showed very low or no expression of caveolin-1 while caveolin-2 expression was similar to the one observed in normal bronchial epithelial cells. 10049753 Human
caveolin-2 tumors Human caveolin-1 and caveolin-2 are closely linked genes colocalized with WI-5336 in a region of 7q31 frequently deleted in tumors. 10087206 Human
cav2 tumor FRA7G is a common fragile site containing the candidate tumor suppressor genes CAV1, CAV2, and TESTIN (TES). 12620387 Human
cav2 gastric cancer The results show that CAV1, CAV2, and TESTIN are not tumor suppressor genes in this gastric cancer. 12620387 Human
cav2 tumor The results show that CAV1, CAV2, and TESTIN are not tumor suppressor genes in this gastric cancer. 12620387 Human
caveolin-2 adenomas In PT cells from adenomas, there are high levels of caveolin-2, variably reduced caveolin-1, and hyperactivation of ERK1/2, which colocalizes with caveolin-1 in some cells, but localizes in the cytosol and nucleus in others. 12970324 Human
caveolin-2 prostate cancer More importantly, we show that caveolin-2 is phosphorylated in vivo at two serine residues and that the phosphorylation of caveolin-2 is necessary for its actions as a positive regulator of caveolin-1 during organelle biogenesis in prostate cancer cells. 12743374 Human
caveolin-2 carcinoma Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. 12813462 Human
caveolin-2 colon carcinoma In human HT-29 colon carcinoma cells, thiazolidinedione PPARgamma ligands increased the levels of caveolin-1 and caveolin-2 proteins two to fivefold in a concentration-dependent manner within 24 h. 12813462 Human
caveolin-2 breast adenocarcinoma In human MCF-7 breast adenocarcinoma cells, nonthiazolidinedione PPARgamma ligands elevated caveolin-2 protein three to fourfold, while the thiazoli-dinediones were less effective. 12813462 Human
caveolin-2 tumor Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. 12866378 Human
caveolin-2 urothelial carcinoma Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. 12866378 Human
cav-2 carcinoma in situ Neither benign urothelium present in 22 cases nor flat carcinoma in situ present in 10 cases stained for Cav-1 or Cav-2. 12866378 Human
cav-2 tumors The percentages of positive cases for Cav-1 in grades 1, 2, and 3 tumors were 0% (0/6), 0% (0/25), and 56% (35/63), respectively (P < .001), and for Cav-2, 0% (0/6), 13% (3/23), and 70% (42/60), respectively (P < .001). 12866378 Human
cav-2 tumor Multivariate analysis showed no significant correlation between tumor stage and Cav-1 or Cav-2 expression after correction for tumor grade. 12866378 Human
cav-2 tumor These results indicate a positive correlation of the expression of Cav-1 and Cav-2 with tumor grade and squamous features of UC and suggest that Cav-1 and Cav-2 be studied further for a possible role in tumor progression and squamous differentiation. 12866378 Human
caveolin-2 pituitary tumour Expression cDNA microarray analysis on bladder cancer cells following E2F3 knockdown was then used to identify genes regulated by E2F3, leading to the identification of known E2F3 targets such as Cyclin A and CDC2 and novel targets including pituitary tum 16909110 Human
caveolin-2 bladder cancer Expression cDNA microarray analysis on bladder cancer cells following E2F3 knockdown was then used to identify genes regulated by E2F3, leading to the identification of known E2F3 targets such as Cyclin A and CDC2 and novel targets including pituitary tum 16909110 Human
cav-2 c6 glioma The purpose of this study is to understand the interaction of Na + -Ca2+ exchanger (NCX1), that is one of the essential regulators of Ca2+ homeostasis, with caveolin (Cav)-1 and Cav-2 in Cav-3 null cell (rat C6 glioma cell). 15814461 Rat
cav-2 c6 glioma Both mRNA and protein expression of NCX1, Cav-1 and Cav-2 was observed, but no expression of mRNA and protein of Cav-3 were observed in C6 glioma cells. 15814461 Rat
cav2 tumor It has been shown previously that the main region of LOH at 7q31 spans the interval between the D7S486 and D7S2460 microsatellite loci, which contains several candidate tumor suppressor genes (TSG) such as TES, CAV2, CAV1, MET, CAPZA2, ST7 and WNT2. 15252854 Human
cav2 prostate tumors We found that CAV1, CAV2, MET and TES mRNA expression was lower in prostate tumors than in normal prostate tissues. 15252854 Human
cav2 breast cancer Caveolin-1 and -2 (CAV1, CAV2) are closely linked genes localised to the fragile region of 7q31 (FRA7G), and loss of heterozygosity involving this region has been reported in breast cancer. 15305200 Human
cav2 breast cancer We examined quantitatively the mRNA levels of CAV1, CAV2 and HER2/neu in 162 cases of breast cancer using real-time PCR. 15305200 Human
cav2 breast cancer We then evaluated for correlations between CAV1, CAV2 and HER2/neu gene expression and clinicopathologic factors in the 162 breast cancer cases. 15305200 Human
cav2 breast cancer Results showed higher HER2/neu mRMA levels and lower CAV1 and CAV2 mRMA levels in breast cancer tissues than in corresponding normal tissues (P<0.001). 15305200 Human
cav2 breast cancer Our results indicated that CAV1 suppression correlated closely with that of CAV2 in breast cancer, that CAV1 level was inversely correlated with tumour size, and that CAV1 and CAV2 levels were correlated with hormonal receptor status. 15305200 Human
cav2 tumour Our results indicated that CAV1 suppression correlated closely with that of CAV2 in breast cancer, that CAV1 level was inversely correlated with tumour size, and that CAV1 and CAV2 levels were correlated with hormonal receptor status. 15305200 Human
cav2 breast cancer Therefore, CAV1 and CAV2 play an important role in tumour progression in breast cancer patients. 15305200 Human
cav2 tumour Therefore, CAV1 and CAV2 play an important role in tumour progression in breast cancer patients. 15305200 Human
caveolin-2 ibd In this study, we evaluated the changes in the caveolin-1 and caveolin-2 expression in the inflamed mucosa of patients with IBD. 11515846 Human
caveolin-2 crohn's disease This enhanced caveolin-2 expression was not detected in active Crohn's disease or ischemic colitis. 11515846 Human
caveolin-2 human breast cancer Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer. 15305200 Human
caveolin-2 glioblastoma In contrast, the expression of caveolin-2 and -3 were downregulated in glioblastoma cells compared to astrocytes. 15273741 Human
caveolin-2 colon carcinoma Caveolin-1 mRNA expression was evident in all colon carcinoma cell lines tested; however, caveolin-2 mRNA was found only in HT-29 and HCT-116. 15069532 Human
caveolin-2 pituitary adenomas No immunoreactivity was seen for caveolin-1 and caveolin-2 in non-tumorous adenohypophysial and neurohypophysial cells and in the tumor cells, indicating that caveolins are not involved in the initiation and progression of pituitary adenomas. 15681859 Human
caveolin-2 tumor No immunoreactivity was seen for caveolin-1 and caveolin-2 in non-tumorous adenohypophysial and neurohypophysial cells and in the tumor cells, indicating that caveolins are not involved in the initiation and progression of pituitary adenomas. 15681859 Human
caveolin-2 pituitary tumors The expression of caveolin-1 and caveolin-2 in the endothelial cells did not depend on age, gender, endocrine status of the patients, morphologic features, and type of pituitary tumors. 15681859 Human
caveolin 2 tumors Analysis of these nine genes has suggested that early-detected tumors have higher levels of retinoic acid production and higher expression levels of caveolin 2, matrix Gla, and cystatin A, which are already known to be lost during tumor progression. 15447986 Human
caveolin 2 tumor Analysis of these nine genes has suggested that early-detected tumors have higher levels of retinoic acid production and higher expression levels of caveolin 2, matrix Gla, and cystatin A, which are already known to be lost during tumor progression. 15447986 Human
cav2 met It has been shown previously that the main region of LOH at 7q31 spans the interval between the D7S486 and D7S2460 microsatellite loci, which contains several candidate tumor suppressor genes (TSG) such as TES, CAV2, CAV1, MET, CAPZA2, ST7 and WNT2. 15252854 Human
cav2 met We found that CAV1, CAV2, MET and TES mRNA expression was lower in prostate tumors than in normal prostate tissues. 15252854 Human
cav2 sclc SCLC lines express many neuronal and neuroendocrine proteins including neuronal calcium channels of the Cav2 family (P/Q and N-type channels). 15269657 Human
cav c6 glioma The purpose of this study is to understand the interaction of Na + -Ca2+ exchanger (NCX1), that is one of the essential regulators of Ca2+ homeostasis, with caveolin (Cav)-1 and Cav-2 in Cav-3 null cell (rat C6 glioma cell). 15814461 Rat
cav urothelial carcinoma (uc) We immunohistochemically evaluated 94 cases of urothelial carcinoma (UC) of the urinary bladder for the expression of caveolin (Cav)-1 and Cav-2. 12866378 Human
cav-2 urothelial carcinoma (uc) We immunohistochemically evaluated 94 cases of urothelial carcinoma (UC) of the urinary bladder for the expression of caveolin (Cav)-1 and Cav-2. 12866378 Human
caveolin-2 c6 glioma In addition, co-localization of caveolin-1/caveolin-2 and caveolin-1/caveolin-3 was detected in both C6 glioma phenotypes. 16135403 Human
caveolin-2 colorectal cancer Using the Methylight assay, TPEF/HPP1 gene methylation was assessed in primary colorectal cancers (n = 47), matched normal colon mucosa, as well as in the liver metastasis of 24 patients with colorectal cancer, and compared to the methylation status of th 16207479 Human
caveolin-2 liver metastasis Using the Methylight assay, TPEF/HPP1 gene methylation was assessed in primary colorectal cancers (n = 47), matched normal colon mucosa, as well as in the liver metastasis of 24 patients with colorectal cancer, and compared to the methylation status of th 16207479 Human
caveolin-2 primary colorectal cancers Using the Methylight assay, TPEF/HPP1 gene methylation was assessed in primary colorectal cancers (n = 47), matched normal colon mucosa, as well as in the liver metastasis of 24 patients with colorectal cancer, and compared to the methylation status of th 16207479 Human
caveolin-2 glomus tumors As a model system, we chose caveolin-1alpha and caveolin-2, two major components of endothelial caveolae, and examined their interaction in the endothelium of vessels in fixed tissues of laboratory animals and human glomus tumors. 16783395 Human
caveolin-2 oncogenic Although caveolin-1 expression is down-regulated in response to oncogenic transformation of NIH 3T3 cells, caveolin-2 protein levels remain unchanged. 9361015 Human
caveolin-2 tumor As this region (6-A2/7q31) is the site of an as yet unidentified tumor suppressor gene(s), our mapping studies clearly define caveolin-1 and caveolin-2 as candidate genes that may be deleted at these loci. 9662443 Human
cav-2 tumor Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). 9662443 Human
cav2 oncogene Our results demonstrate that CAV1, CAV2, and TESTIN are coamplified with the MET oncogene and overexpressed in GTL-16. 12620387 Human
cav2 adenocarcinomas In stage I adenocarcinomas, CAV2 protein expression correlated with shorter survival. 15095482 Human
caveolin-2 c6 glioma Light-density, Triton X-100-insoluble caveolin-1- and caveolin-2-enriched fractions were obtained after fractionation of rat C6 glioma cells and their separation over 5-40% discontinuous sucrose-density gradients. 10568687 Rat
caveolin-2 tumorigenesis We studied the expression of caveolin-1 and caveolin-2 in normal epithelium, adenoma, and adenocarcinoma of the colon and their possible role in tumorigenesis. 11345836 Human
caveolin-2 escc RESULTS: The results of cDNA arrays showed that 13 cancer-related genes were up-regulated > or =2-fold (CDC25B, cyclin D1, PCNA, MET, Jagged 2, Integrin alpha3, Integrin alpha6, Integrin beta4, Caveolin-2, Caveolin-1, MMP13, MMP14, and BIGH3) and 5 genes 11705871 Human
caveolin-2 adenocarcinoma While caveolin-1 was overexpressed in all experimental adenocarcinoma tissues by comparison to normal-appearing colonic mucosa at both the mRNA and protein level, caveolin-2 was expressed equally only at the mRNA level in both tissues. 15069532 Human
caveolin-2 oncogenic Shift syndecan-2 from RACK1 to caveolin-2 upon transformation with oncogenic ras. 16997272 Rat
caveolin-2 oncogenic Syndecan-2 was found to detach from RACK1 and associate with caveolin-2 and Ras in cells transformed with oncogenic ras. 16997272 Rat
caveolin-2 oncogenic The finding of syndecan-2 reactive with caveolin-2/Ras suggests the molecular complex most likely to obstruct RACK1 for functional attachment at syndecan-2, as revealed in cells transfected with oncogenic ras. 16997272 Rat
cav2 esophageal squamous cell carcinoma (escc) We investigated the relationship between the clinicopathological factors of esophageal squamous cell carcinoma (ESCC) and the expression of CAV1 and CAV2. 17671707 Human
cav2 esophageal cancer CAV1 and CAV2 expression were analyzed by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in 15 esophageal cancer cell lines (TE1-15) and a normal esophageal epithelium cell line (Het-1A). 17671707 Human
cav2 escc CAV1 and CAV2 expression was examined by RT-PCR and immunohistochemical analysis in 47 ESCC specimens. 17671707 Human
cav2 escc In the ESCC samples CAV1 and CAV2 mRNA expression in the ESCC samples were significantly higher than in the corresponding normal esophageal mucosa (CAV1, P=0.0024; CAV2, P=0.0136). 17671707 Human
cav2 escc These results suggest that positive staining for CAV1 and CAV2 could be a potentially useful prognostic marker of ESCC. 17671707 Human
caveolin-2 tumor The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. 17671707 Human
caveolin-2 esophageal squamous cell carcinoma The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. 17671707 Human
caveolin-2 c6 glioma We also found that caveolin-1, caveolin-2, or Cav-1 S80E formed immunoprecipitable complexes with EAAC1 in C6 glioma and/or transfected HEK cells. 17715130 Human
caveolin-2 hcc METHODS: Paraffin sections of 35 HCC specimens were immunostained with caveolin-1, caveolin-2, alpha-smooth muscle actin, and CD34 antibodies. 17898556 Human
cav2 breast cancer BACKGROUND: The aims of this study were to define the distribution of caveolin 2 (CAV2) in frozen and formalin fixed, paraffin embedded (FFPE) normal breast samples and the significance of CAV2 expression in breast cancer. 17912630 Human
cav2 invasive breast carcinomas CAV2 expression was also immunohistochemically analysed in two independent cohorts of invasive breast carcinomas (n = 245 and n = 418). 17912630 Human
cav2 breast cancers CAV2 expression was observed in 9.6% of all breast cancers and was strongly correlated with high histological grade, lack of oestrogen receptor, progesterone receptor and cyclin D1 expression, and positivity for epidermal growth factor receptor, basal mar 17912630 Human
cav2 cancers CONCLUSION: Our results demonstrate that CAV2 is preferentially expressed in basal-like cancers and is associated with poor prognosis. 17912630 Human
cav2 oncogenic Further in vitro studies are required to determine whether CAV2 has oncogenic properties or is only a surrogate marker of basal-like carcinomas. 17912630 Human
cav2 carcinomas Further in vitro studies are required to determine whether CAV2 has oncogenic properties or is only a surrogate marker of basal-like carcinomas. 17912630 Human
cav2 invasive breast cancer Caveolin-1 and CAV2 protein expression was assessed on a tissue microarray containing 880 unselected invasive breast cancer cases, by means of immunohistochemistry. 18612310 Human
cav2 breast cancer Caveolin-1 and CAV2 expression was observed in 13.4 and 5.9% of all breast cancer, respectively. 18612310 Human
caveolin 2 invasive breast cancer Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis. 17912630 Human
caveolin 2 breast cancer BACKGROUND: The aims of this study were to define the distribution of caveolin 2 (CAV2) in frozen and formalin fixed, paraffin embedded (FFPE) normal breast samples and the significance of CAV2 expression in breast cancer. 17912630 Human
caveolin 2 breast cancer Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. 18612310 Human

< Top >


Download all image files.
Save all PNG files.    Save all PDF files.    Save all PS files.